Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 551 - Advancement in Stem Cell Cures and Therapies Act › Subchapter 1 - General Provisions › Section 310:551-1-2 - Definitions

Current through Vol. 41, No. 20, July 1, 2024
The following words or terms, when used in this Chapter,
				  shall have the following meaning, unless the context clearly indicates
				  otherwise.
"Adult stem cell"
means undifferentiated cells,
				  found throughout the body after embryonic development, that multiply by cell
				  division to replenish dying cells and regenerate damaged tissues. These stem
				  cell types include but are not limited to, Adipose stem cells (ASC), Connective
				  Tissue Progenitors (CTP), Hematopoietic stem cells (HSC), Hemangioblast (AC133)
				  from umbilical cell blood (HB1), Mesenchymal Stem Cells (MSC), Multi-potent
				  adult stem cells (MAPC), Neural stem cells/oligodendrocyte progenitors (NSC),
				  Skeletal myoblast (SKMS), and Umbilical cord blood derived stem cells
				  (UCB).
"Board"
means the Oklahoma State Board of
				  Health.
"Classification"
means the business form of the
				  information provider.
"Commissioner"
means the Commissioner of the
				  Oklahoma State Department of Health or his designated representative.
"Completed report"
means a submitted data file
				  that has been reviewed by the Department and found to contain no observed
				  errors.
"Data element"
means a unit of specific
				  information collected and recorded by the Department that identifies the
				  persons and entities engaged in stem cell research in Oklahoma and the nature
				  of the stem cell research being conducted.
"Data file"
means an electronic file containing
				  data elements.
"Data provider"
means either an information
				  provider or an IRB who agrees to provide informationon behalf of an information
				  provider.
"Department"
means the Oklahoma State Department
				  of Health.
"Donor"
means the person or entity with legal
				  custody of a fertilyzed egg or oocyte.
"Embryonic stem cell"
means cells derived from
				  embryos that develop from eggs that have been fertilized in vitro and then
				  lawfully donated for research purposes with informed consent of the
				  donor.
"Human Embryo"
refers to a living
				  organism of the species Homo sapiens at the earliest stage of development,
				  including the single-cell stage, that is not located in the body of a woman.
				  [1-270.2 of Title 63]
"Human tissue regeneration"
means any cell-based
				  therapy that involves the regeneration of human tissue using stem cells.
"Information provider"
means a private or public
				  institution or other entity, or a person who is not affiliated with an
				  institution or entity, that has initiated or is conducting research.
"IRB"
or
"Institutional Review
				  Board"
means the body or committee that is established in accordance
				  with federal law and charged with the responsibility to provide oversight
				  functions within a private or public institution where biomedical research
				  involving human subjects is being conducted or performed. An IRB may include a
				  Stem Cell Research Oversight Committee.
"Research"
means any work, labor or effort into
				  discovering, discerning or advancing knowledge of the science of cell
				  regeneration.
"Somatic cell nuclear transfer"
means a
				  laboratory technique for creating an ovum with a donor nucleus.
"Stem cell"
means an adult stem cell or an
				  embryonic stem cell.
Added at 26 Ok Reg 2040,
				  eff 6-25-09